|
|
|
|
Jason Grier Elected To Board Of Cystinosis Research Foundation
Software executive Jason Grier has been elected to the Board of Directors of the Cystinosis Research Foundation of Irvine, Calif., the largest non-profit provider of funds for research to develop a cure for cystinosis, a deadly...
|
|
|
Jason Grier Elected To Board Of Cystinosis Research Foundation
Software executive Jason Grier has been elected to the Board of Directors of the of Irvine, Calif., the largest non-profit provider of funds for research to develop a cure for cystinosis, a deadly metabolic disease that afflicts about 500...
|
|
|
Cystinosis - Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystin
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly We're a pay-per-view site for premium content.If you'd like to purchase this article, it's only $3.00. Raptor Pharmaceuticals Doses First Patient in...
|
|
|
Raptor Pharmaceuticals Doses First Patient In Phase 2b Clinical Trial Of DR Cysteamine For Cystinosis
Raptor Pharmaceuticals Logo.(PRNewsFoto/Raptor Pharmaceuticals Corp.) NOVATO, CA UNITED STATES Novato, CA /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), today announced...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC:RPTP) (BULLETIN BOARD: RPTP) , today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in...
|
|
|
$2.3 Million Raised for Cystinosis Research
Mitch Albom, author of best-selling memoir Tuesdays With Morrie, along with a $1-million challenge grant helped raise $2.3 million for Natalies Wish, the fundraiser for the Cystinosis Research Foundation.All CRF donations go to...
|
|
|
Raptor Pharmaceuticals Doses First Patient In Phase 2b Clinical Trial Of DR Cysteamine For Cystinosis
Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in collaboration with the University of California, San Diego (...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO ) The Phase 2b clinical trial will enroll up to six cystinosis...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') , today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in collaboration with the University...
|
|
|
Raptor Pharmaceutical Inc. Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') , today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in collaboration with the University...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') , today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in collaboration with the University...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') , today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in collaboration with the University of California, San Diego ('UCSD'), to evaluate...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') , today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in collaboration with the University...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') , today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in collaboration with the University...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in collaboration with the University of California, San...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP - News), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
Article Tools Story Tools NOVATO, Calif., June 1 /CNW/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in...
|
|
|
Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
NOVATO, Calif., June 1 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp.('Raptor' or the 'Company') (OTC Bulletin Board: RPTP), today announced that it has dosed the first patient in its Phase 2b clinical trial, conducted in...
|
